Cargando…

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

BACKGROUND: Molecular subtyping of urothelial cancer (UC) has significantly advanced the understanding of bladder tumor heterogeneity and development of prognostic and predictive biomarkers. Evolving evidence across cancers strongly suggests that tumor immunoediting has a profound impact on the beha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidotto, Thiago, Nersesian, Sarah, Graham, Charles, Siemens, D. Robert, Koti, Madhuri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556053/ https://www.ncbi.nlm.nih.gov/pubmed/31174611 http://dx.doi.org/10.1186/s40425-019-0619-8

Ejemplares similares

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance
por: Ren, Runhan, et al.
Publicado: (2017)

Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint
por: Chenard, Stephen, et al.
Publicado: (2021)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model
por: Zhang, Yongqing, et al.
Publicado: (2021)

BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
por: Koti, Madhuri, et al.
Publicado: (2020)

Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer
por: Hamade, Ali, et al.
Publicado: (2022)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2017)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2018)

Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer
por: Jackson, Chelsea L, et al.
Publicado: (2021)

Emerging role of PTEN loss in evasion of the immune response to tumours
por: Vidotto, Thiago, et al.
Publicado: (2020)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020)

Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures
por: Huang, Xiaoli, et al.
Publicado: (2020)

Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer
por: Sangster, Ami G., et al.
Publicado: (2022)

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
por: Bejrananda, Tanan, et al.
Publicado: (2022)

Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer
por: Sanguedolce, Francesca, et al.
Publicado: (2023)

Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes
por: Chen, Zihao, et al.
Publicado: (2021)

Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
por: Yang, Yong, et al.
Publicado: (2022)

Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study
por: Brennan, Kelly, et al.
Publicado: (2018)

Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing
por: Wang, Fangming, et al.
Publicado: (2022)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy
por: Wang, Haojie, et al.
Publicado: (2022)

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
por: Liu, David, et al.
Publicado: (2017)

Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
por: Bugoye, Fidelis Charles, et al.
Publicado: (2023)

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy
por: Sakano, S, et al.
Publicado: (2006)

Biological determinants of bladder cancer gene expression subtypes
por: Aine, Mattias, et al.
Publicado: (2015)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer
por: Vidotto, Thiago, et al.
Publicado: (2018)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment
por: Ecke, Thorsten H., et al.
Publicado: (2022)

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens
por: Koll, Florestan J., et al.
Publicado: (2023)

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
por: Herrmann, Jonas, et al.
Publicado: (2021)

High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
por: Mei, Ping, et al.
Publicado: (2020)

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes
por: Andrieu, Charlotte, et al.
Publicado: (2022)

Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer
por: Abbosh, Philip H., et al.
Publicado: (2018)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Lindskrog, Sia Viborg, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d8kq71d80fg21hj0ftpnioccor